Growth Metrics

Quest Diagnostics (DGX) Gross Profit (2016 - 2025)

Quest Diagnostics' Gross Profit history spans 18 years, with the latest figure at $942.0 million for Q1 2026.

  • On a quarterly basis, Gross Profit rose 9.15% to $942.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.7 billion, a 12.23% increase, with the full-year FY2025 number at $3.7 billion, up 12.98% from a year prior.
  • Gross Profit hit $942.0 million in Q1 2026 for Quest Diagnostics, up from $910.0 million in the prior quarter.
  • Over the last five years, Gross Profit for DGX hit a ceiling of $965.0 million in Q1 2022 and a floor of $736.0 million in Q4 2023.
  • Historically, Gross Profit has averaged $843.4 million across 5 years, with a median of $842.0 million in 2022.
  • Biggest five-year swings in Gross Profit: fell 26.12% in 2022 and later grew 17.29% in 2025.
  • Tracing DGX's Gross Profit over 5 years: stood at $758.0 million in 2022, then fell by 2.9% to $736.0 million in 2023, then increased by 16.58% to $858.0 million in 2024, then increased by 6.06% to $910.0 million in 2025, then grew by 3.52% to $942.0 million in 2026.
  • Business Quant data shows Gross Profit for DGX at $942.0 million in Q1 2026, $910.0 million in Q4 2025, and $949.0 million in Q3 2025.